Hanall Biopharma Revenue

In the year 2025, Hanall Biopharma had annual revenue of 155.18B KRW with 11.69% growth. Hanall Biopharma had revenue of 37.55B in the quarter ending December 31, 2025, with 3.11% growth.

Revenue

155.18B

Revenue Growth

+11.69%

P/S Ratio

16.85

Revenue / Employee

510.48M

Employees

304

Market Cap

2,615.21B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	155.18B	16.24B	11.69%
Dec 31, 2024	138.94B	4.03B	2.99%
Dec 31, 2023	134.91B	24.91B	22.65%
Dec 31, 2022	110.00B	8.40B	8.27%
Dec 31, 2021	101.59B	12.99B	14.66%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Celltrion Pharm	274.73B
Daewoong Pharmaceutical	1,570.89B
GC Biopharma	1,991.28B
Chong Kun Dang Pharmaceutical	1,692.40B
DongKook Pharmaceutical	926.88B
Hanmi Pharm.	1,547.53B
Yuhan	2,186.64B
Daewoong	2,068.37B

Revenue Rankings